| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7449ca99fbf1c556219fe28876cbf2a9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf51cafccc85b82aeda595cba36e1470 |
| publicationDate |
2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011229469-A1 |
| titleOfInvention |
Methods for the treatment of cancer |
| abstract |
Methods for treating cancer with at least one HGF-Met inhibitor and at least one EGFR inhibitor are provided |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433064-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11124482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014121239-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11142578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9598400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9133162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091439-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091440-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098015-B2 |
| priorityDate |
2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |